Our orders are delivered strictly on time without delay
Our orders are delivered strictly on time without delay
Following the guidelines of the United States Preventive Service Taskforce (USPSTF), discuss and describe the screening recommendations for the following:
· Cervical cancer
· Breast cancer
· Osteoporosis
· Colorectal cancer
· Lung cancer
· Ovarian cancer
· Intimate partner violence (IPV).
| Population | Recommendation | Screening Method & Interval |
|---|---|---|
| Asymptomatic Women | Grade D (Discouraged) | Recommends against screening asymptomatic women who are not known to be at high genetic risk. |
| Justification | Screening (typically using transvaginal ultrasound and CA-125 tests) has been shown to have no benefit in reducing mortality and carries significant harm due to high rates of false-positive results and subsequent unnecessary surgeries. |
| Population | Recommendation | Screening Method & Interval |
|---|---|---|
| Women of Reproductive Age | Grade B | Clinicians should screen all women of reproductive age for IPV. |
| Screening Action | Provide or refer women who screen positive to intervention services (e.g., counseling, support groups). | |
| Older/Vulnerable Adults | Grade I | Current evidence is insufficient to recommend for or against screening for abuse and neglect in asymptomatic, cognitively intact older or vulnerable adults. |
The U.S. Preventive Services Task Force (USPSTF) provides evidence-based recommendations for clinical preventive services. These recommendations are specific regarding the target population, age range, and frequency of screening.